NHF Cardholders to Benefit from New Drugs

NHF Cardholders

 Kingston, Jamaica (Mckoy’s News) – NHF Cardholders to Benefit from New Drugs: The National Health Fund, NHF cardholders are to benefit from the addition of new drugs for the treatment of Breast Cancer and Arthritis.

New for the treatment of Breast Cancer are Faslodex Injection with the active ingredient Fulvestrant for which NHF offers a subsidy of close to $40,000 per 250mg injection and Gemcit Injection with the active ingredient gemcitabine hydrochloride with a subsidy of $2,000 per 200mg injection and $10,400 per 1g injection.

Reditux Injection with the active ingredient Rituximab with a subsidy of $13,300 per 100mg injection and $66,100 per 500mg injection has been added for the treatment of Arthritis.

These changes came into effect October 12 this year.

A complete drug list and subsidies paid by the NHF are available from NHF participating Pharmacies, the NHF website or by calling NHF at 1-888-NHF-CARE.


Contributed by Dr. Colin O Jarrett